Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

NASDAQ:XMTR - Nasdaq - US98423F1093 - Common Stock - Currency: USD

32.62  +1.1 (+3.49%)

After market: 32.5 -0.12 (-0.37%)

Fundamental Rating

3

Taking everything into account, XMTR scores 3 out of 10 in our fundamental rating. XMTR was compared to 48 industry peers in the Trading Companies & Distributors industry. While XMTR seems to be doing ok healthwise, there are quite some concerns on its profitability. XMTR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XMTR had positive earnings in the past year.
In the past year XMTR has reported a negative cash flow from operations.
XMTR had negative earnings in each of the past 5 years.
In the past 5 years XMTR always reported negative operating cash flow.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -7.08%, XMTR is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
XMTR has a worse Return On Equity (-15.77%) than 87.50% of its industry peers.
Industry RankSector Rank
ROA -7.08%
ROE -15.77%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

XMTR's Gross Margin of 39.05% is fine compared to the rest of the industry. XMTR outperforms 68.75% of its industry peers.
XMTR's Gross Margin has improved in the last couple of years.
XMTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XMTR has more shares outstanding
The number of shares outstanding for XMTR has been increased compared to 5 years ago.
XMTR has a worse debt/assets ratio than last year.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.74 indicates that XMTR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of XMTR (2.74) is worse than 60.42% of its industry peers.
A Debt/Equity ratio of 0.92 indicates that XMTR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.92, XMTR is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 2.74
ROIC/WACCN/A
WACC9.61%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 3.74 indicates that XMTR has no problem at all paying its short term obligations.
XMTR has a Current ratio of 3.74. This is amongst the best in the industry. XMTR outperforms 83.33% of its industry peers.
XMTR has a Quick Ratio of 3.70. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.70, XMTR belongs to the top of the industry, outperforming 97.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.74
Quick Ratio 3.7
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 128.13% over the past year.
The Revenue has grown by 19.36% in the past year. This is quite good.
The Revenue has been growing by 46.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)128.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)19.36%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%23.05%

3.2 Future

The Earnings Per Share is expected to grow by 189.04% on average over the next years. This is a very strong growth
Based on estimates for the next years, XMTR will show a quite strong growth in Revenue. The Revenue will grow by 17.49% on average per year.
EPS Next Y683.44%
EPS Next 2Y301.43%
EPS Next 3Y189.04%
EPS Next 5YN/A
Revenue Next Year19.61%
Revenue Next 2Y18.39%
Revenue Next 3Y17.67%
Revenue Next 5Y17.49%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 362.44, the valuation of XMTR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of XMTR indicates a slightly more expensive valuation: XMTR is more expensive than 75.00% of the companies listed in the same industry.
XMTR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.04.
XMTR is valuated quite expensively with a Price/Forward Earnings ratio of 46.22.
XMTR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. XMTR is more expensive than 77.08% of the companies in the same industry.
XMTR is valuated rather expensively when we compare the Price/Forward Earnings ratio to 37.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 362.44
Fwd PE 46.22
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

XMTR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XMTR's earnings are expected to grow with 189.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y301.43%
EPS Next 3Y189.04%

More info and screens

0

5. Dividend

5.1 Amount

XMTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOMETRY INC-A

NASDAQ:XMTR (7/25/2025, 8:00:01 PM)

After market: 32.5 -0.12 (-0.37%)

32.62

+1.1 (+3.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners93.25%
Inst Owner Change-0.03%
Ins Owners5.8%
Ins Owner Change16.2%
Market Cap1.65B
Analysts80
Price Target35.83 (9.84%)
Short Float %12.83%
Short Ratio8.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)321.09%
Min EPS beat(2)100.56%
Max EPS beat(2)541.62%
EPS beat(4)4
Avg EPS beat(4)229.77%
Min EPS beat(4)92.16%
Max EPS beat(4)541.62%
EPS beat(8)8
Avg EPS beat(8)128.87%
EPS beat(12)11
Avg EPS beat(12)92.36%
EPS beat(16)13
Avg EPS beat(16)50.37%
Revenue beat(2)0
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)-0.07%
Revenue beat(4)2
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.55%
Revenue beat(12)5
Avg Revenue beat(12)-0.89%
Revenue beat(16)9
Avg Revenue beat(16)-0.06%
PT rev (1m)0.68%
PT rev (3m)-1.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.5%
EPS NY rev (1m)0%
EPS NY rev (3m)1.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 362.44
Fwd PE 46.22
P/S 2.88
P/FCF N/A
P/OCF N/A
P/B 5.33
P/tB 105.65
EV/EBITDA N/A
EPS(TTM)0.09
EY0.28%
EPS(NY)0.71
Fwd EY2.16%
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS11.32
BVpS6.11
TBVpS0.31
PEG (NY)0.53
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.08%
ROE -15.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.05%
FCFM N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.47%
Cap/Sales 3.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.74
Quick Ratio 3.7
Altman-Z 2.74
F-Score4
WACC9.61%
ROIC/WACCN/A
Cap/Depr(3y)161.93%
Cap/Depr(5y)158.79%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y683.44%
EPS Next 2Y301.43%
EPS Next 3Y189.04%
EPS Next 5YN/A
Revenue 1Y (TTM)19.36%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%23.05%
Revenue Next Year19.61%
Revenue Next 2Y18.39%
Revenue Next 3Y17.67%
Revenue Next 5Y17.49%
EBIT growth 1Y24.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.26%
EBIT Next 3Y88.55%
EBIT Next 5Y63.98%
FCF growth 1Y62.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.6%
OCF growth 3YN/A
OCF growth 5YN/A